Literature DB >> 9296251

Use of gabapentin in pain management.

C H Wetzel1, J F Connelly.   

Abstract

There have been many proposed uses for gabapentin, including midscapular pain secondary to radiation myelopathy, RSD, neuropathic pain, postherpetic neuralgia, and migraine prophylaxis. However, the published reports consist of a small number of patients and limited data. Limited data provided in published case reports do not allow adequate evaluation of expected adverse effects or efficacy. It is unclear whether gabapentin is more effective for a specific type of pain and how gabapentin may compare with placebo or other therapeutic alternatives. Therefore, randomized, double-blind, placebo-controlled, prospective studies are warranted to further elucidate gabapentin uses beyond what is recommended by the Food and Drug Administration. Gabapentin should only be considered for pain management after well-established therapies have failed to produce desired outcomes.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9296251     DOI: 10.1177/106002809703100920

Source DB:  PubMed          Journal:  Ann Pharmacother        ISSN: 1060-0280            Impact factor:   3.154


  5 in total

Review 1.  Treatment of amyotrophic lateral sclerosis.

Authors:  A Eisen; M Weber
Journal:  Drugs Aging       Date:  1999-03       Impact factor: 3.923

Review 2.  Drug interactions with patient-controlled analgesia.

Authors:  Jorn Lotsch; Carsten Skarke; Irmgard Tegeder; Gerd Geisslinger
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

Review 3.  The neurobiology of skeletal pain.

Authors:  Patrick W Mantyh
Journal:  Eur J Neurosci       Date:  2014-02       Impact factor: 3.386

4.  Pain and psychiatry: a critical analysis and pharmacological review.

Authors:  Donatella Marazziti; Francesco Mungai; Laura Vivarelli; Silvio Presta; Bernardo Dell'Osso
Journal:  Clin Pract Epidemiol Ment Health       Date:  2006-11-06

5.  HPLC Analytical Method Development and Validation of Gabapentin through Chemical Derivatization with Catechol as a Chromophore.

Authors:  Murad Abualhasan; Fairouz Shraim; Hiba Alawni; Saba Hamdan; Hadeel Khaseeb
Journal:  Int J Anal Chem       Date:  2022-10-03       Impact factor: 1.698

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.